176 related articles for article (PubMed ID: 2838987)
1. Use of peptides for immunization against foot-and-mouth disease.
Brown F
Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987
[TBL] [Abstract][Full Text] [Related]
2. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine.
Huang H; Yang Z; Xu Q; Sheng Z; Xie Y; Yan W; You Y; Sun L; Zheng Z
Viral Immunol; 1999; 12(1):1-8. PubMed ID: 10333237
[TBL] [Abstract][Full Text] [Related]
3. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
[TBL] [Abstract][Full Text] [Related]
4. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
[TBL] [Abstract][Full Text] [Related]
5. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
Vasantha S; Antony A; Lal SM
Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
[TBL] [Abstract][Full Text] [Related]
6. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides as potential vaccines against foot-and-mouth disease.
Brown F
Endeavour; 1990; 14(2):87-94. PubMed ID: 1697533
[TBL] [Abstract][Full Text] [Related]
8. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
[TBL] [Abstract][Full Text] [Related]
10. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals.
Broekhuijsen MP; van Rijn JM; Blom AJ; Pouwels PH; Enger-Valk BE; Brown F; Francis MJ
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3137-43. PubMed ID: 2447225
[TBL] [Abstract][Full Text] [Related]
11. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
[TBL] [Abstract][Full Text] [Related]
12. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.
Doel TR; Gale C; Do Amaral CM; Mulcahy G; Dimarchi R
J Virol; 1990 May; 64(5):2260-4. PubMed ID: 2157884
[TBL] [Abstract][Full Text] [Related]
13. [Neutralization of foot-and-mouth disease virus O1 Campos by antibodies induced by a synthetic peptide].
Piccone M; Zuloaga G; Marcovecchio F; Arese A; Monesiglio JC; Palma EL
Rev Argent Microbiol; 1988; 20(2):69-75. PubMed ID: 2845477
[TBL] [Abstract][Full Text] [Related]
14. Immunological priming with synthetic peptides of foot-and-mouth disease virus.
Francis MJ; Fry CM; Rowlands DJ; Brown F; Bittle JL; Houghten RA; Lerner RA
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2347-54. PubMed ID: 2997370
[TBL] [Abstract][Full Text] [Related]
15. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.
Francis MJ; Hastings GZ; Brown F; McDermed J; Lu YA; Tam JP
Immunology; 1991 Jul; 73(3):249-54. PubMed ID: 1652552
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
Rao MG; Butchaiah G; Sen AK
Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
[TBL] [Abstract][Full Text] [Related]
17. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
Doel TR; Gale C; Brooke G; DiMarchi R
J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
[TBL] [Abstract][Full Text] [Related]
18. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
Borca MV; Moore DM; Srikumaran S; Morgan DO
Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
[TBL] [Abstract][Full Text] [Related]
19. Synthetic peptide vaccines against foot and mouth disease.
Murdin AD
Vaccine; 1986 Dec; 4(4):210-1. PubMed ID: 3026104
[TBL] [Abstract][Full Text] [Related]
20. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi R; Little S; Gale C
Adv Exp Med Biol; 1991; 303():211-20. PubMed ID: 1725233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
